A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.
Chin Med J (Engl)
; 2022 Jul 25.
Article
de En
| MEDLINE
| ID: mdl-35861301
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Langue:
En
Journal:
Chin Med J (Engl)
Année:
2022
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Chine